Merck KGaA (OTCMKTS:MKGAF – Get Free Report) shares passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $149.69 and traded as low as $142.08. Merck KGaA shares last traded at $142.08, with a volume of 496 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, The Goldman Sachs Group upgraded Merck KGaA to a “strong-buy” rating in a report on Thursday, September 19th.
Check Out Our Latest Analysis on Merck KGaA
Merck KGaA Stock Performance
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Further Reading
- Five stocks we like better than Merck KGaA
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.